Medicare and Insurance Policy Updates in 2023 Will Improve Cancer Screening Access by Removing Patient Colonoscopy Cost Following a Positive Cologuard Test
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, supports recent policy changes that help increase access to recommended non-invasive colorectal cancer screening tests.
Recent News & Updates
The care that older adults with advanced cancer receive often does not align with their preferences and values, study findings suggest.
Cancer is becoming increasingly common among young people, with cases slowly and steadily rising every year for the past decade.
My patient Claire and I were at odds. She was 44 years old and came to my clinic for a second opinion. The diagnosis was stage 3 rectal cancer.
Come mid-2026, it will be 11 years since my oncologist asked, “What would you think about being treated as if you were early stage?”
